Peijia Medical Ltd (HKG: 9996) has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its second-generation balloon dilation catheter, Taurus Atlas Pro. This non-compliant balloon is designed for percutaneous transluminal valvuloplasty of the pulmonary valve.
The Taurus Atlas Pro balloon dilation catheter is offered in 11 models and specifications, with an effective length of 40mm, catering to expansion needs ranging from 10-28mm, and is suitable for a variety of surgical procedures. The second-generation product boasts an enhanced inner tube design, which facilitates the transmission of pushing force and enhances pushing performance compared to the first generation. Additionally, the balloon body has been strengthened, significantly improving its resistance to compression and reducing the risk of balloon rupture during surgery.
The product also includes an extension tube and a coil, which simplifies the preparation and operation of the balloon during surgery, reducing the risk of intraoperative contamination. This makes the Taurus Atlas Pro not only safe but also convenient for medical professionals to use.
This regulatory approval is a significant milestone for Peijia Medical, highlighting the company’s commitment to advancing cardiovascular interventional devices and enhancing patient care.- Flcube.com
